Harvey Dong

Harvey Dong is an accomplished professional with extensive experience in the field of diagnostics and biotechnology. Currently serving as Vice President of Global CDx Business at Amoy Diagnostics since November 2015, Harvey Dong has held various leadership positions including Senior Director and Director of Business Development, where responsibilities focus on developing companion diagnostic collaborations with pharmaceutical companies. Prior to Amoy Diagnostics, Harvey Dong contributed to AstraZeneca as Senior Associate Scientist in Translational Science and Associate Scientist in Tumor Genetics, emphasizing genetic data generation and capability development. Harvey Dong began a career at Adicon Clinical Laboratories, Inc., designing and developing molecular assays for cancer diagnostics. Educational qualifications include a Master’s degree in Biochemistry and Molecular Biology and a Bachelor’s degree in Biotechnology from South-Central University for Nationalities.